Value Of I-131 Spect/Ct For The Evaluation Of Differentiated Thyroid Cancer: A Systematic Review Of The Literature

Yan-Li Xue,Zhong-Ling Qiu,Hong-Jun Song,Quan-Yong Luo
DOI: https://doi.org/10.1007/s00259-012-2310-x
2013-01-01
Abstract:In the present study, we performed a systematic review of the current literature to assess the incremental value of I-131 single photon emission computed tomography (SPECT)/CT for the management of patients with differentiated thyroid cancer (DTC).The search of PubMed/MEDLINE and EMBASE databases to identify studies and reference lists for articles was conducted using the terms "SPECT or SPECT/CT or SPECT-CT or single photon emission computed tomography/computed tomography and thyroid carcinoma or thyroid cancer." Studies reporting the clinical value of I-131 SPECT/CT were selected. All studies included were assessed with the Quality Assessment of Diagnostic Accuracy Studies-2 tool (QUADAS-2). Two independent reviewers selected the studies, summarized and tabulated the data, and pooled estimates were obtained. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed.A total of 14 studies involving 1,066 patients met the inclusion criteria. Data obtained included the impact of I-131 SPECT/CT on staging or risk classification (three studies), diagnostic accuracy (six studies), and follow-up (five studies).Integrated SPECT/CT is a useful tool for the diagnosis, staging, risk stratification, and follow-up of DTC. The impact of I-131 SPECT/CT on the management of patients with thyroid cancer was evaluated.
What problem does this paper attempt to address?